psychosocial support

How to Cite

Dilaruri, A., & Rahmawati, I. (2020). THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA. Belitung Nursing Journal, 6(3), 97–102.
Google Scholar

Link to Google Scholar

Accepted for publication: 2020-06-02
Peer reviewed: Yes

Related articles in

Search Relations - Article by Author(s)


Background: COVID-19 is caused by the 2019 novel coronavirus (2019nCoV) which was identified on 7 January 2020 by the Chinese Center for Disease Control and Prevention (CDC) from the throat swab sample of a patient. This novel coronavirus is phylogenetically similar to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS outbreak in 2002.

Objective: To describe a case of a COVID -19 patient in a hospital in Indonesia.

Case Report: A 55-year-old male was admitted to the Emergency Department of Arifin Achmad Hospital on 31 March 2020. He was transferred from a private hospital after three days of hospitalization. Previously, he came to another hospital complaining palpitation, cough, having difficulty of breathing, and intermittent fever. He then was advised to be admitted and tested for a COVID-19 test. At first, he did not admit to having traveled recently. After three days, the pharyngeal swab test was received confirming that he was contracted with COVID-19. The patient was then transferred to our hospital and hospitalized for ten days.

Discussion: The patient was fully recovered after ten days of treatment with antiviral drug namely Oseltamivir 75 mg orally twice a day and chloroquine phosphate 500 mg twice a day orally. The combination of both drugs showed an immune-modulating activity which might increase its antiviral effects. Therefore, the use of this agent in COVID-19 patients might be worthwhile. During hospitalization, reducing patient anxiety was also one of our main goals as many studies has found that anxiety is associated with poor immune system.

Conclusion: This case report demonstrated the current situation in Indonesia where people become reluctant to fully disclose their symptoms or travel history to the health care workers, which may put many others on the risk of being transmitted with the virus. Although the proven efficacy of chloroquine is still lacking, it has become the favorable choice at this moment as indicated in our study. Reducing the patient’s anxiety towards the disease may help to speed the patient’s recovery. Also, we need to educate public that COVID-19 might be a life-threatening disease but it is also a treatable disease.


Copyright (c) 2020 Ade Dilaruri, Ira Rahmawati

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article Metrics

Total views 1732 [Abstract: 1163 | PDF: 569 ]


Download data is not yet available.

PlumX Metrics


Ahn, D. G., Shin, H. J., Kim, M. H., Lee, S., Kim, H. S., Myoung, J., . . . Kim, S. J. (2020). Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel Coronavirus Disease 2019 (COVID-19). Journal of Microbiology and Biotechnology, 30(3), 313-324.

Bhardwaj, A. K., & Agrawal, G. (2015). Concept and applications of psycho-immunity (defense against mental illness): Importance in mental health scenario. Online Journal of Multidisciplinary Researches (OJMR), 1(3), 6.

Chamberlain, S. R., Cavanagh, J., de Boer, P., Mondelli, V., Jones, D. N. C., Drevets, W. C., . . . Bullmore, E. T. (2019). Treatment-resistant depression and peripheral C-reactive protein. British Journal of Psychiatry, 214(1), 11-19.

Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., . . . Yuen, K.-Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, 395(10223), 514-523.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., . . . Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223), 507-513.

Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020). A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Journal of Critical Care.

Depoux, A., Martin, S., Karafillakis, E., Bsd, R. P., Wilder-Smith, A., & Larson, H. (2020). The pandemic of social media panic travels faster than the COVID-19 outbreak. Journal of Travel Medicine.

Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., . . . Ziebuhr, J. (2020). Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus study group. BioRxiv, 2020.2002.2007.937862.

Guan, W.-j., Liang, W.-h., Zhao, Y., Liang, H.-r., Chen, Z.-s., Li, Y.-m., . . . He, J.-x. (2020). Comorbidity and its impact on 1590 patients with Covid-19 in China: A nationwide analysis. European Respiratory Journal, 2000547.

Gunawan, J., Juthamanee, S., & Aungsuroch, Y. (2020). Current mental health Issues in theeEra of Covid-19. Asian Journal of Psychiatry, 51, 102103-102103.

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., . . . Pillai, S. K. (2020). First case of 2019 novel coronavirus in the United States. New England Journal of Medicine, 382(10), 929-936.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., . . . Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497-506.

Jin, Y., Yang, H., Ji, W., Wu, W., & Chen, S. (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. 12(4).

Lai, C. C., Liu, Y. H., Wang, C. Y., Wang, Y. H., Hsueh, S. C., Yen, M. Y., . . . Hsueh, P. R. (2020). Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. Journal of Microbiology, Immunology and Infection.

Larson, H. J. (2018). The biggest pandemic risk? Viral misinformation. Nature, 562(7727), 309.

Liu, P., Chen, W., & Chen, J.-P. (2019). Viral metagenomics revealed sendai virus and coronavirus infection of Malayan Pangolins (Manis javanica). Viruses, 11(11), 979.

Lutgendorf, S. K., Weinrib, A. Z., Penedo, F., Russell, D., DeGeest, K., Costanzo, E. S., . . . Lubaroff, D. M. (2008). Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. Journal of Clinical Oncology, 26(29), 4820-4827.

Ministry of Health of the Republic of Indonesia. (2020). Infeksi emerging: Media informasi resmi terkini penyakit infeksi emerging [Emerging infections: The latest official information media for emerging infectious diseases]. Jakarta: Ministry of Health of the Republic of Indonesia.

Paton, N. I., Lee, L., Xu, Y., Ooi, E. E., Cheung, Y. B., Archuleta, S., . . . Wilder-Smith, A. (2011). Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial. Lancet Infectious Disease, 11(9), 677-683.

Rahmawati, I., & Pertami, S. B. (2019). HIV screening test in a newly diagnosed TB patient: A case study. International Journal of Nursing and Health Services (IJNHS), 2(4), 198-204.

Rubin, E. J., Baden, L. R., & Morrissey, S. (2020). Audio interview: Caring for patients with Covid-19. New England Journal of Medicine, 382(16), e50.

Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. https://10.1001/jama.2020.6019

Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006). New insights into the antiviral effects of chloroquine. Lancet Infectious Disease, 6(2), 67-69.

Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020). Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes & metabolic syndrome, 14(3), 241-246.

Wang, B., Li, R., Lu, Z., & Huang, Y. (2020a). Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY), 12.

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., . . . Hu, Z. (2020b). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. 30(3), 269-271.

World Health Organization. (2020). Novel coronavirus (2019 nCoV) situation report - 85. Retrieved from

Yan, Y., Zou, Z., Sun, Y., Li, X., Xu, K. F., Wei, Y., . . . Jiang, C. (2013). Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Research, 23(2), 300-302.

Yazdany, J., & Kim, A. H. J. (2020). Use of Hydroxychloroquine and Chloroquine during the COVID-19 pandemic: What Every clinician should know. Annals of Internal Medicine.

Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., . . . Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-273.

Readers are able to give us their valuable feedbacks here. The comments will be reviewed by the editors and then published here. Important Note: The "Comments" related to the Galley Proof PDF must NOT be submitted via this form. Authors should submit their comments on their galley proofs only via system